Caplin Point Laboratories Limited (CAPLIPOINT) Share Analysis
NSE · Healthcare · Healthcare
Caplin Point Laboratories Limited (NSE: CAPLIPOINT) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹2,749.00, market capitalisation ₹20,893 Cr, P/E 31.4, ROE 20.9%.
Get the AI verdict on CAPLIPOINT: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
CAPLIPOINT price and valuation
- Share price
- ₹2,749.00
- Market cap
- ₹20,893 Cr
- P/E ratio
- 31.4
- P/B ratio
- 6.21
- EPS
- ₹87.53
- Book value per share
- ₹443.00
- Dividend yield
- 0.29%
CAPLIPOINT profitability and growth
- ROE
- 20.9%
- ROCE
- 24.2%
- Debt to equity
- 0
- Revenue growth (3 yr)
- 14%
- Revenue growth (5 yr)
- 16%
- Profit growth (3 yr)
- 19%
- Profit growth (5 yr)
- 21%
CAPLIPOINT 52-week range
- 52-week high
- ₹2,877.30
- 52-week low
- ₹1,500.30
- Face value
- ₹2.00
CAPLIPOINT shareholding pattern
- Promoters
- 70.57%
- FIIs
- 5.76%
- DIIs
- 2.49%
- Public
- 21.19%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.